Drugs / nanocrystalline hydroxyapatite
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03588507 | Sep 2018 → Sep 2019 | periodontitis | Cairo University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | nanocrystalline hydroxyapatite | “nanocrystalline hydroxyapatite bone graft substitute(Dentaurum, Germany) will be placed within the defect” NCT03588507 ↗ |
| Known as | nano-HA | “The purpose of the present randomized controlled clinical study was to compare the clinical outcomes of papilla preservation flap surgery with or without the application of a...” PMID 19680697 ↗ Aug 2009 |